This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Global Audiological Devices Industry

NEW YORK, Dec. 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Audiological Devices Industry

http://www.reportlinker.com/p098388/Global-Audiological-Devices-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

This report analyzes the worldwide markets for Audiological Devices in US$ Million by the following Product Segments: Hearing Aids (Behind-the-ear, In-the-ear, In-the-canal, & Completely-in-the-canal), Measurement/Testing Devices (Otoscopes, Audiometers, Impedence Analyzers, Hearing Aid Analyzers, & Others), and Cochlear Implants. Further, the global Hearing Aids market is analyzed in '000 units for geographic regions including the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a five-year historic analysis is provided for these markets. The report profiles 62 companies including many key and niche players such as Cochlear Limited, GN Resound A/S, Med-EL Medical Electronics, Neurelec SA, Otovation LLC, Siemens Audiologische Technik GmbH, Starkey Laboratories, Inc., Sonova Holding AG, Advanced Bionics Corporation, Phonak AG, Widex A/S, William Demant Holding, Bernafon AG, Sonic Innovations, and Oticon A/S. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Hearing Aids I-4Behind-The-Ear Hearing Aid I-4In-The-Ear (ITE) Hearing Aid I-4In-The-Canal (ITC) Hearing Aid I-4Completely-In-The Canal (CIC) Hearing Aid I-4Measurement/Testing Devices I-4Otoscopes I-4Audiometers I-4Impedance Analyzers I-5Hearing Aid Analyzers I-5Other Measurement/Testing Devices I-5Cochlear Implants I-5II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW AND ANALYSIS II-1

A Primer II-1

Developed Markets Lead the Suite in Sales II-1

Hearing Aids - Maintain Their Dominance II-2

1 of 20

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs